PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,031 | +273.3% | 13,725 | +433.8% | 0.00% | – |
| Q2 2023 | $2,419 | +7459.4% | 2,571 | -92.2% | 0.00% | -100.0% |
| Q1 2023 | $32 | -46.7% | 33,049 | -24.2% | 0.00% | -50.0% |
| Q4 2022 | $60 | -99.9% | 43,596 | +4.7% | 0.00% | +100.0% |
| Q3 2022 | $52,000 | +2.0% | 41,625 | +89.9% | 0.00% | 0.0% |
| Q2 2022 | $51,000 | +6.2% | 21,919 | +41.2% | 0.00% | – |
| Q1 2022 | $48,000 | +380.0% | 15,523 | +865.4% | 0.00% | – |
| Q4 2021 | $10,000 | -54.5% | 1,608 | -26.1% | 0.00% | -100.0% |
| Q3 2021 | $22,000 | -72.8% | 2,177 | -64.6% | 0.00% | -50.0% |
| Q2 2021 | $81,000 | +47.3% | 6,142 | +97.0% | 0.00% | +100.0% |
| Q1 2021 | $55,000 | +139.1% | 3,118 | +250.7% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | -85.8% | 889 | -92.8% | 0.00% | -50.0% |
| Q3 2020 | $162,000 | +671.4% | 12,382 | +1508.1% | 0.00% | +100.0% |
| Q2 2020 | $21,000 | +950.0% | 770 | +427.4% | 0.00% | – |
| Q1 2020 | $2,000 | – | 146 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |